Early Amiodarone in Shockable Cardiac Arrest

Part of paid clinical trials in Portland, Oregon.

Sponsor
Oregon Health and Science University
Study ID
NCT06680869
Phase
PHASE3
Status
Recruiting

Conditions

  • Cardiac Arrest

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Amiodarone Hydrochloride Injection — DRUG
    The use of a modified treatment protocol by emergency medical services where the initial dose of amiodarone is given after the second defibrillator shock, during the same two-minute cycle as the initial dose of epinephrine, for out-of-hospital cardiac arrest due to a shockable rhythm (ventricular fibrillation or ventricular tachycardia) that is persistent or recurs after at least one defibrillation attempt. If an EMS agency is assigned to this arm, no downstream care after the initial dose of amiodarone is dictated by the study.
  • Usual Care Protocol — OTHER
    The use of a usual care treatment protocol by emergency medical services where the initial dose of amiodarone is given after the third defibrillator shock, one two-minute cycle after the initial dose of epinephrine, for out-of-hospital cardiac arrest due to a shockable rhythm (ventricular fibrillation or ventricular tachycardia) that is persistent or recurs after at least one defibrillation attempt. If an EMS agency is assigned to this arm, no downstream care after the initial dose of amiodarone is dictated by the study.

Study Details

The primary objective of this pilot, pragmatic stepped-wedge cluster randomized trial is to evaluate if a modified cardiac arrest treatment algorithm calling for the administration of the initial amiodarone dose one 2-minute cycle earlier than current guidelines (during the same cycle as the initial dose of epinephrine) improves the time to amiodarone delivery in those with out-of-hospital cardiac arrest due to refractory ventricular fibrillation or ventricular tachycardia compared to usual care.

Key Dates

Start date
Jan 1, 2025
Status verified
Dec 2025
Primary completion
Dec 31, 2027
Completion
Jan 31, 2028

Study Design

Enrollment
585 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Early Amiodarone Protocol
    Amiodarone administration after the second defibrillator shock, during the same two-minute cycle as the initial dose of epinephrine.
  • Active Comparator: Usual Care Protocol
    Amiodarone administration after the third defibrillator shock, one two-minute cycle after the initial dose of epinephrine.

Primary Outcome Measure

Time from emergency medical services (EMS) arrival on-scene (or time of arrest if witnessed by EMS) to the administration of the initial dose of amiodarone in minutes [ Time Frame: up to 1 day ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Oregon Health & Sciences UniversityPortlandOregon97035
Joshua Lupton, MD, MPH
503-418-6706
Joshua Lupton, MD, MPH (PRINCIPAL_INVESTIGATOR)

Find similar trials in Portland, OR

Related Studies